Collaborations and Alliances

Laureate Biopharma continues its collaboration via a joint-marketing relationship with Selexis SA, a Swiss based contract developer of high performance production cell lines, This expanded relationship provides streamlined access to a set of highly complementary contract services and offers the opportunity to generate highly productive, stable mammalian cells producing gram quantities of recombinant protein materials in as little as eight weeks, post transfection. In parallel, cGMP compliant manufacturing processes can be developed for a streamlined approach for the production of clinical-grade material.

In Feb 2007 Laureate announced a preferred partnership agreement with Boehringer Ingelheim, one of the leading companies in biopharmaceutical development and manufacturing. With this collaboration, Laureate’s clients may gain access to Boehringer Ingelheim’s comprehensive manufacturing technology platform for biopharmaceutical products produced by mammalian cell culture.

Through this collaboration, Laureate Biopharma will now offer its clients bioprocessing services that include: creation and development of production cell lines using Boehringer Ingelheim’s highly efficient BI HEX expression system; full-service process development and manufacture of early stage clinical supplies at Laureate’s cGMP manufacturing facility in Princeton, NJ; and access to large-scale commercial production by Boehringer Ingelheim at its facility in Biberach, Germany. Compatible bioprocessing methods at Laureate and Boehringer Ingelheim will make a seamless transfer of manufacturing activities from Laureate to Boehringer Ingelheim possible.